Summary by Futu AI
HighTide Therapeutics, Inc. (HighTide Therapeutics, Inc.) will hold its Annual General Meeting via virtual conference on May 16, 2024 at 2:00 p.m. The meeting will address issues including the granting of general mandates to issue shares, resale inventory shares and repurchase shares, re-election of retiring directors, and the renewal of auditors. If shareholders are unable to attend in person, they may complete the proxy form and return it 48 hours prior to the meeting. The Company was incorporated in the Cayman Islands on 28 February 2018 and listed on the main board of the Hong Kong Stock Exchange Limited on 22 December 2023. The relevant documents of the Annual General Meeting have been published on the Company's website and on the Exchange website.